complex
antivir
immun
mechan
involv
adapt
innat
reaction
mediat
cd
lymphocyt
whose
uniqu
immunosurveil
contribut
analyz
differ
clinic
experiment
set
beyond
doubt
fast
potent
cytotox
well
noncytolyt
antivir
activ
cd
cell
critic
protect
host
divers
viral
pathogen
murin
cd
cell
first
lineag
lymphocyt
appear
mous
thymu
later
predomin
epithelia
intestin
lymphoid
dendrit
epiderm
cd
cell
develop
normal
athym
mhc
class
iiidefici
mice
express
distinct
vgene
segment
mark
differ
subset
often
associ
moreorless
specif
preponder
exampl
epidermi
lung
tongu
uterusvagina
intestin
epithelium
review
circul
murin
cd
cell
mainli
express
tcell
receptor
tcr
chain
structur
recogn
murin
cd
cell
includ
ie
k
heatshock
protein
hsvgi
stress
epitheli
cell
howev
cd
tcell
stimulatori
activ
murin
cd
ligand
examin
vivo
rodent
model
assess
therapeut
potenti
activ
cd
cell
except
human
cd
tcell
test
scid
mice
similarli
mous
express
human
cd
tcr
variabl
segment
associ
tissu
prevalencefor
instanc
tcell
subset
appear
larg
resid
characterist
wherea
lymphocyt
frequent
adult
peripher
blood
human
cell
form
larg
subpopul
gut
skin
lung
lymphocyt
cell
seem
recogn
tcr
andor
micab
stressmolecul
receptor
contrast
human
cell
main
bloodlymphoid
organ
cd
tcell
subpopul
typic
recogn
phosphomonoest
molecul
synthes
mevalon
doxp
metabol
pathway
sinc
cd
cell
display
potent
antivir
activ
mani
differ
virus
may
possibl
design
novel
antivir
therapi
util
activ
cd
cell
involv
cd
cell
antivir
immunosurveil
extens
analyz
tabl
larg
number
studi
indic
cd
cell
particip
immun
respons
human
immunodefici
viru
hiv
review
retroviru
human
tcell
leukemia
viru
htlv
type
simian
immunodefici
viru
siv
murin
leukemia
viru
mulv
extrathym
expans
tcrd
clonotyp
among
cell
found
correl
presenc
endogen
mulv
inbr
mice
genotypeindepend
extrathym
expans
cd
tcell
subset
also
report
human
nonhuman
primat
upon
siv
infect
rhesu
monkey
macaca
mulatta
transient
increas
percentag
cell
observ
cd
cell
sivinfect
macaqu
appear
express
activ
marker
memori
marker
differ
uninfect
anim
simian
cd
cell
also
abl
suppress
siv
replic
vitro
assess
antigenemia
signific
increas
cd
cell
elut
rectal
mucosa
observ
protect
versu
sivinfect
macaqu
vaccin
attenu
siv
protect
pathogen
viru
mucos
challeng
site
accompani
expans
cd
cell
concomitantli
dendrit
cell
investig
mechan
protect
reveal
simian
cd
cell
gener
antivir
factor
rant
prevent
siv
infect
compet
coreceptor
similarli
homo
sapien
sever
studi
suggest
potent
antivir
activ
cell
hiv
human
cell
exert
cytolyt
noncytolyt
induct
bchemokin
rant
antivir
activ
efficaci
inhibit
compar
lymphocyt
moreov
human
cell
shown
releas
adefensin
yet
unidentifi
noncytolyt
antivir
factor
increas
rel
absolut
number
cd
cell
describ
peripher
blood
person
includ
free
opportunist
pathogen
increas
due
tcell
subset
result
invers
adult
peripher
blood
ratio
hivseroneg
control
augment
represent
tcell
subset
peripher
blood
hivseroposit
person
independ
particular
cchain
express
correl
select
associ
particular
junction
motif
correl
high
level
antigenemia
moreov
comparison
mucos
blood
cd
cell
reveal
similar
increas
cell
compart
antiretrovir
treatment
abl
restor
cell
normal
level
indic
factor
hiv
replic
respons
tcell
expans
increas
express
natur
killer
receptor
found
cell
hiv
patient
may
due
chronic
activ
cell
person
cell
abl
lyse
uninfect
bystand
cell
hiv
infect
indic
tcell
subset
may
directli
contribut
hivassoci
immunopathogenesi
hivassoci
tcell
increas
accompani
polyclon
tcell
decreas
peripher
blood
mucos
tissu
situat
even
low
number
cell
remain
hiv
infect
frequent
anerg
although
influenc
cytokin
product
normal
cell
neither
abl
revers
tcell
anergi
observ
hivinfect
patient
although
spectrotyp
analysi
reveal
signific
differ
hiv
individu
compar
uninfect
control
signific
chang
observ
altern
nomenclatur
chain
repertoir
among
possibl
combin
four
known
jc
segment
healthi
adult
preferenti
express
jcp
chain
combin
pair
also
associ
strongest
respons
nonpeptid
antigen
npag
even
though
respons
still
polyclon
typic
cell
stimul
npag
mainli
exhibit
jcp
rearrang
altern
known
also
gene
transfer
studi
shown
combin
associ
strong
npag
respons
wherea
tcr
contain
combin
appear
somewhat
less
respons
lysin
residu
within
jcp
segment
uniqu
absent
human
jc
segment
mutat
lysin
residu
complet
abrog
respons
npag
without
affect
respons
monoclon
antibodi
mab
suggest
posit
charg
lysin
residu
tcrc
region
encod
germlin
jcp
segment
play
key
role
respons
npag
hivinfect
individu
substanti
reduc
number
cell
rearrang
alter
reduc
tcell
reactiv
shown
partial
revers
toward
normal
level
highli
activ
antiretrovir
therapi
haart
treatment
deplet
cell
earliest
known
tcrspecif
cell
delet
associ
hiv
infect
importantli
loss
cell
may
contribut
factor
establish
viral
persist
aid
reduc
level
type
cytokin
hivinfect
person
undergo
structur
treatment
interrupt
sti
loss
circul
cell
observ
suggest
acut
hiv
replic
may
influenc
homeostasi
specif
reduct
cd
tcell
number
evid
effector
tcell
subset
addit
npagdriven
interferonc
ifnc
product
substanti
decreas
sti
haart
resumpt
ensu
inhibit
hiv
replic
tcell
reactiv
restor
altogeth
observ
indic
cell
activ
soon
initi
activ
hiv
replic
rapidli
lost
hivinfect
person
fail
control
viremia
context
noteworthi
tcell
loss
observ
stiinduc
increas
plasma
hivrna
could
mimic
statu
found
earli
phase
hiv
infect
summari
data
indic
soon
plasma
hivrna
rebound
tcell
subset
becom
rapidli
anerg
subsequ
deplet
mechan
loss
may
involv
activationinduc
cell
death
reactiv
clone
trigger
fasfasl
interact
npag
thu
antivir
potenti
cell
rapidli
diminish
hiv
replic
furthermor
increas
subset
may
result
clonal
expans
respons
hivrath
may
bystand
effect
induc
cytokin
chang
occur
hiv
diseas
progress
addit
hivrel
molecul
may
interfer
cd
tcell
homeostasi
sinc
tat
seem
compet
chemokin
bind
receptor
express
cd
cell
expans
activ
cd
tcell
subset
observ
hepat
c
viru
hcv
patient
flaviviru
infect
gb
viru
c
west
nile
viru
wnv
intrahepat
lymphocyt
patient
chronic
hepat
c
high
histolog
activ
index
score
liver
carri
mostli
cd
tcr
liver
cd
tcell
line
hcvinfect
individu
exhibit
high
level
mhcunrestrict
cytotox
activ
differ
target
includ
primari
hepatocyt
produc
ifnc
tumor
necrosi
factora
tnfa
follow
activ
liver
cd
tcell
line
recogn
structur
nonstructur
protein
hcv
cytotox
activ
cell
infect
recombin
vaccinia
virus
express
differ
hcv
protein
howev
crosslink
bind
hcv
particl
result
signific
ifnc
tnfa
product
liver
cd
cell
moreov
tcell
subset
polyclon
activ
recruit
liver
chronic
hcvinfect
patient
chronic
hcv
infect
tcell
subset
may
releas
cytokin
thu
contribut
inflammatori
necrot
process
liver
hivhcv
coinfect
patient
show
increas
frequenc
peripher
intrahepat
natur
lymphocyt
may
result
higher
degre
hepat
inflamm
comparison
patient
liver
diseas
altogeth
find
suggest
cell
may
play
role
hcvassoci
liver
patholog
contrast
tcell
decreas
may
contribut
impair
cellular
immun
respons
persist
natur
hcv
diseas
chronic
hcv
infect
similarli
hiv
infect
tcell
impair
eg
intrahepat
cell
expand
cours
diseas
also
observ
tcell
deficit
may
associ
persist
viral
infect
human
infect
gb
virustyp
c
gbvc
genet
similar
hcv
rel
common
worldwid
convinc
evid
gbvc
infect
caus
human
patholog
nevertheless
current
interest
gbvc
fuell
report
indic
hivinfect
patient
coinfect
gbvc
slower
diseas
progress
recent
studi
among
hivinfect
mother
south
africa
show
mother
coinfect
gbvc
higher
percentag
circul
cd
cell
hivinfect
mother
without
gbvc
infect
howev
cohort
hivinfect
patient
found
correl
tcell
tcell
increas
gbvc
coinfect
martini
et
al
clin
infect
di
perhap
futur
studi
investig
associ
circul
cd
tcell
frequenc
gbvc
load
particular
clinic
set
may
elucid
whether
cd
tcell
increas
directli
relat
gbvc
infect
west
nile
viru
wnv
flaviviru
transmit
mosquito
recent
emerg
new
york
citi
metropolitan
area
spread
central
part
us
clinic
manifest
rang
asymptomat
seroconvers
fatal
meningoenceph
wnv
also
caus
fatal
meningoenceph
laboratori
mice
use
model
shown
mice
defici
cell
suscept
wnv
infect
tcrdmice
elev
viral
load
greater
viral
dissemin
central
nervou
system
adopt
transfer
cd
cell
tcrdmice
reduc
suscept
mice
wnv
effect
primarili
due
ifncproduc
cell
data
demonstr
distinct
antivir
role
cd
cell
control
wnv
infect
mous
cd
cell
activ
home
site
viral
replic
paramyxoand
orthomyxoviru
infect
mous
model
epitheli
tcell
respons
respiratori
syncyti
viru
rsv
infect
domin
ab
cell
cd
cell
present
h
sapien
mitogenstimul
cd
cell
peripher
blood
infant
acut
rsv
infect
produc
significantli
less
ifnc
cd
cell
infant
acut
reoviru
infect
convalesc
percentag
cd
cell
produc
ifnc
increas
children
recov
fulli
children
develop
postbronchiolit
wheez
suggest
cytokin
product
cd
cell
acut
rsv
infect
may
play
role
develop
recurr
wheez
rsv
infect
cd
cell
form
minor
lunginfiltr
lymphocyt
mice
infect
sendai
viru
paramyxoviru
caus
nonfat
pneumonia
phenotyp
preval
throughout
cours
sendai
viru
infect
transit
phenotyp
preponder
occur
late
resolut
inflamm
measl
paramyxoviru
infect
expans
human
cell
vitro
neg
regul
measl
viru
glycoprotein
viral
immunomodul
depend
interact
viru
glycoprotein
surfac
molecul
present
cd
cell
monocyt
studi
cd
tcell
involv
orthomyxoviru
infect
perform
mice
sinc
bronchoalveolar
lavag
bal
popul
influenza
virusinfect
mice
express
high
frequenc
cd
tcr
chain
mrna
week
influenza
infect
inflammatori
exud
lung
consist
larg
macrophag
cd
cell
earli
increas
cell
late
increas
cell
sinc
increas
number
macrophag
express
heatshock
protein
hsp
mrna
found
increas
cell
consist
possibl
least
lymphocyt
respond
hspposit
cell
resolut
inflammatori
process
cd
tcell
hybridoma
establish
influenza
virusinfect
mice
respond
influenza
virusinfect
stimul
recombin
interestingli
hybridoma
obtain
uninfect
mous
also
respond
influenza
virusinfect
cell
indic
could
inde
target
antigen
tcr
variabl
cgene
usag
buccal
epithelium
normal
mice
mice
challeng
local
influenza
viru
infect
differ
control
mice
restrict
use
vc
gene
buccal
cd
cell
consist
primarili
express
gene
diminish
influenzainfect
mice
express
vc
gene
appear
alter
infect
local
challeng
bsa
follow
decreas
express
gene
lesser
extent
gene
wherea
gene
express
increas
possibl
specul
immunomodul
effect
oral
antigen
exposur
buccal
cd
cell
suggest
cell
function
involv
local
immun
respons
replic
nonrepl
antigen
oral
mucos
surfac
liganddepend
lytic
function
studi
mice
influenza
pneumonia
cd
cell
constitut
cytotox
recov
directli
site
virusinduc
damag
respiratori
tract
howev
could
display
cytotox
activ
stimul
presenc
mab
low
concentr
activ
cd
cell
show
profound
cytotox
target
cell
express
ha
either
subtyp
mhcunrestrict
manner
substanti
number
lung
cd
cell
constitut
express
mrna
varieti
cytokin
replic
vigor
cell
express
mrna
ifnc
predomin
among
cd
cell
recov
inflammatori
exud
frequenc
cytokin
mrna
lymphocyt
much
higher
expect
frequenc
virusspecif
cell
may
suggest
involv
innat
immun
reaction
predict
immunosuppress
drug
cyclosporin
diminish
resist
mice
influenza
viru
infect
mice
inocul
intraven
tdm
glycolipid
compon
mycobacteri
cell
wall
regain
resist
influenza
viru
infect
impair
cyclosporin
like
better
outcom
tdmtreat
mice
due
activ
especi
cd
lymphocyt
sinc
tcell
subpopul
increas
markedli
lung
tdmtreat
mice
cd
cell
studi
immun
respons
rna
virus
coxsackievirus
murin
coronavirus
vesicular
stomat
viru
role
cd
cell
demonstr
coxsackievirusinduc
myocard
cell
express
cd
tcr
account
lymphocyt
infiltr
heart
coxsackieviru
infect
mice
adopt
transfer
cd
cell
produc
ifncinduc
myocard
apoptosi
pathogen
cd
tcell
respons
link
mhc
class
ii
haplotyp
sinc
anim
lack
mhc
class
ii
ie
antigen
develop
minim
cardiac
lesion
subsequ
infect
despit
high
concentr
viru
heart
suscept
myocard
correl
ifncposit
cell
respons
spleen
wherea
diseas
resist
associ
posit
phenotyp
cd
tcell
analysi
indic
distinct
cell
subpopul
activ
infect
resist
suscept
mice
deplet
cd
cell
abrog
myocard
suscept
ie
anim
result
versu
phenotyp
shift
appear
cd
cell
modul
tcell
respons
select
lyse
cell
lysi
requir
direct
celltocel
interact
cd
tcell
target
like
mediat
fasfasl
interact
heart
infiltr
myocarditissuscept
mice
contain
abund
cell
wherea
heartinfiltr
cell
plenti
myocarditisresist
mice
interestingli
mabinduc
deplet
cell
potenti
myocard
wherea
mabinduc
deplet
cell
lead
suppress
myocard
transfer
experi
myocarditisresist
mice
show
subset
promot
myocard
th
subset
analys
suggest
cell
induc
domin
respons
wherea
cell
bring
domin
respons
infect
myocarditisinduc
strain
preferenti
activ
cell
strongli
posit
ifnc
wherea
cell
increas
myocarditisinduc
strain
myocarditisnoninduc
strain
infect
anim
model
system
molecul
requir
stimul
cell
activ
cell
initi
myocard
ifncmedi
induct
cell
turn
activ
autoimmun
ab
effector
respons
activ
cell
adopt
transfer
myocard
anim
infect
nonmyocardit
variant
either
uninfect
recipi
demonstr
myocardit
function
requir
infect
express
contrast
ab
cell
transfer
myocard
either
infect
uninfect
recipi
show
function
activ
effector
virusand
thu
cell
influenc
pathogen
abil
manipul
adapt
immun
respons
murin
model
coronaviru
infect
induc
mous
hepat
viru
mhv
cd
cell
major
tcell
effector
found
predominantli
area
viru
antigen
infect
mice
mhv
result
acut
chronic
demyelin
mani
similar
multipl
sclerosi
h
sapien
also
fact
patholog
process
mediat
cd
cell
compat
possibl
involv
cd
cell
pathogenesi
multipl
sclerosi
mhvinfect
mice
cd
cell
may
function
lyse
infect
target
cell
secret
proinflammatori
cytokin
like
contribut
activ
macrophagesmicrogli
cell
final
effector
diseas
process
possibl
antivir
role
cd
lymphocyt
may
relat
abil
promot
bcell
help
specif
cd
cell
abl
provid
signal
requir
immunoglobulin
isotyp
switch
vesicular
stomat
viru
infect
immunocompet
mice
differ
immunoregulatori
function
mediat
cd
lymphocyt
b
andor
dc
cell
may
vari
depend
viral
agent
cd
tcell
subset
involv
antivir
respons
involv
cd
cell
natur
immun
infect
caus
dna
virus
well
establish
tabl
particular
mani
studi
describ
protect
role
cd
lymphocyt
immunosurveil
herpesvirus
rodent
peopl
murin
model
herp
simplex
viru
hsv
infect
cd
tcell
clone
recogn
glycoprotein
hsv
type
without
requir
express
mhc
class
class
ii
gene
product
isol
studi
hsv
diseas
cours
tcrcdor
tcrabdefici
mice
shown
cd
cell
limit
sever
epitheli
lesion
greatli
reduc
mortal
prevent
develop
lethal
viral
enceph
protect
due
cd
cellmedi
arrest
viral
replic
neurovirul
corneal
hsv
infect
mice
cd
lymphocyt
abl
infiltr
trigemin
ganglion
cell
produc
ifnc
suggest
direct
role
cd
cell
control
viru
replic
product
antivir
molecul
hsvspecif
cd
cell
isol
infect
person
abl
express
hsvspecif
cytotox
activ
mediat
lytic
activ
virusspecif
ctl
requir
express
hla
class
molecul
surfac
target
cell
howev
respons
appear
hlaunrestrict
suggest
possibl
involv
nk
receptor
express
human
cd
cell
specif
pbmc
hsvseroposit
individu
stimul
autolog
hsvinfect
pha
blast
show
expans
cell
abl
lyse
hsvinfect
mockinfect
target
also
cell
obtain
pha
mycobacteri
stimul
abl
lyse
hsvinfect
well
unrel
vacciniainfect
target
mockinfect
target
similarli
mous
model
human
cd
cellmedi
cytotox
activ
restrict
classic
hla
class
class
ii
molecul
block
mab
cd
tcr
interestingli
cd
cell
shown
suscept
human
herp
viru
hhv
infect
display
cytolyt
activ
autolog
heterolog
target
cell
infect
infect
induc
express
cd
lymphocyt
render
suscept
hiv
thu
evolv
strategi
interfer
cd
tcell
antivir
activ
exploit
activ
cell
expand
pool
target
cell
suscept
product
infect
lymphocyt
bear
cd
tcr
expand
herpesviru
infect
acut
phase
epsteinbarr
viru
ebv
induc
infecti
mononucleosi
cd
cell
express
activ
antigen
hladr
persist
convalesc
phase
infecti
mononucleosi
suggest
possibl
role
cd
cell
control
primari
ebv
infect
larg
proport
human
sinovi
tissueand
peripher
bloodderiv
tcell
clone
prolifer
respons
stimul
autolog
allogen
ebvtransform
blymphoblastoid
cell
line
lcl
prolif
respons
depend
contact
respond
stimul
cell
block
mab
antibodi
cd
complex
subsequ
studi
natur
stimulatori
ligand
found
cellular
rather
viral
origin
express
upregul
upon
activ
b
cell
moreov
express
molecul
surfac
activ
b
cell
appear
crucial
sinc
antibodi
structur
block
induct
tcell
prolifer
final
predomin
vdj
sequenc
found
among
lclrespons
tcell
clone
argu
strongli
monoor
oligoclon
tcell
respons
lcl
murin
model
cytomegaloviru
mcmv
infect
number
cd
cell
increas
liver
periton
caviti
day
reach
peak
day
intraperiton
infect
cd
cell
show
activ
tcell
phenotyp
larg
express
may
recogn
mcmvinduc
cd
cell
express
ifnc
tnfa
abl
produc
ifnc
vitro
respons
moreov
deplet
cd
cell
antitcr
cd
mab
treatment
result
signific
increas
viru
titer
parallel
decreas
ifnc
liver
day
mcmv
infect
support
import
cd
cell
earli
protect
infect
anoth
studi
phenotyp
function
characterist
leukocyt
infiltr
submaxillari
gland
smg
analyz
cmvinfect
balbc
mice
robust
innat
immun
respons
compris
mhc
ii
dendrit
cell
cd
cell
promin
least
day
postinfect
express
ifnc
cc
chemokin
extraordinarili
high
smg
respons
mcmv
infect
indic
innat
acquir
immun
respons
quit
vigor
smg
cmvinfect
mice
rat
model
accumul
cd
cell
region
poplit
lymph
node
pln
start
day
inocul
cmv
footpad
pln
cd
cell
inhibit
plaqu
develop
spread
cmv
infect
neg
receptor
prolifer
respons
contain
high
level
ifnc
ifnc
posit
correl
cure
fibroblast
viru
infect
dramat
expans
cd
cell
peripher
blood
note
posttranspl
human
cytomegaloviru
hcmv
infect
increas
associ
activ
cd
cell
express
mainli
tcr
chain
analys
tcr
junction
divers
reveal
hcmv
infect
accompani
select
expans
cell
bear
recurr
junction
amino
acid
motif
suggest
vivo
antigendriven
select
cd
tcell
subset
cours
hcmv
infect
cell
hcmvinfect
kidney
recipi
abl
prolifer
vitro
presenc
free
cmv
virion
cmvinfect
fibroblast
lysat
presenc
uninfect
herpesvirusinfect
fibroblast
lysat
suggest
popul
cd
cell
may
play
import
role
immun
respons
hcmv
infect
relationship
evolut
cmv
infect
kinet
cd
tcell
amplif
follow
month
transplant
patient
late
cd
tcell
expans
day
significantli
longer
p
higher
p
antigenemia
symptomat
patient
earli
expans
moreov
singl
patient
analys
shown
cd
tcell
expans
parallel
resolut
cmv
infect
strongli
support
idea
protect
role
cd
cell
hcmv
infect
increas
cd
cell
hepat
b
viru
hbv
seroconvers
describ
conceiv
cell
may
involv
hbv
immunosurveil
maintain
low
viru
level
seroconvers
role
cd
cell
innat
resist
vaccinia
viru
vv
infect
studi
use
normal
aband
cdtcrdefici
mice
mice
defici
cd
cell
significantli
higher
vv
titer
increas
mortal
comparison
normal
mice
rapid
profound
vvinduc
increas
ifncproduc
cd
cell
periton
caviti
spleen
abtcrdefici
vvinfect
mice
rapid
respons
occur
absenc
prime
substanti
number
vvspecif
cd
cell
present
uninfect
mice
cell
express
constitut
cytolyt
activ
increas
vv
infect
vvinfect
abdefici
mice
show
transient
control
vv
replic
day
cd
tcell
respons
peak
thereaft
cd
tcell
number
declin
viru
infect
recrudesc
thu
cd
cell
mediat
innat
immun
virus
signific
impact
viru
replic
presenc
absenc
adapt
immun
respons
h
sapien
role
cd
cell
assess
vaccin
subject
receiv
live
recombin
canarypox
viru
express
hiv
protein
solubl
mn
canarypox
viru
vaccin
induc
increas
cd
tcell
respons
detect
secondari
vitro
expans
augment
cd
tcell
respons
specif
canarypox
viru
hiv
antigen
mediat
primarili
ifncproduc
cell
cd
tcell
line
gener
canarypox
vaccine
respond
canarypox
antigen
mycobacteri
antigen
increas
ifnc
product
cd
cell
may
boost
induct
protect
type
memori
immun
augment
effect
live
vaccin
clearli
cd
cell
play
import
role
innat
adapt
immun
respons
viral
infect
molecul
recogn
cd
cell
viral
infect
probabl
cellular
rather
viral
origin
appear
metabolit
alter
cellular
pathway
particular
product
mevalon
pathway
moreov
virusexpos
cd
cell
rapidli
activ
type
interferon
ifna
ifnb
phenomenon
like
contribut
effect
antivir
respons
antivir
role
cd
cell
intens
studi
mice
correl
product
ifnc
distinct
cd
tcell
subset
h
sapien
cell
system
local
expand
chronic
viral
infect
probabl
involv
accompani
inflammatori
process
cell
activ
earli
acut
phase
viral
infect
display
potent
antivir
respons
moreov
plethora
solubl
factor
antivir
characterist
induc
molecul
influenc
outcom
viral
infect
addit
direct
antivir
properti
mani
molecul
play
crucial
immunoregulatori
role
decis
control
complex
antivir
immunosurveil
function
well
establish
correct
immunolog
memori
environ
vivo
